Your browser doesn't support javascript.
loading
Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging.
Strittmatter, Nicole; Kanvatirth, Panchali; Inglese, Paolo; Race, Alan M; Nilsson, Anna; Dannhorn, Andreas; Kudo, Hiromi; Goldin, Robert D; Ling, Stephanie; Wong, Edmond; Seeliger, Frank; Serra, Maria Paola; Hoffmann, Scott; Maglennon, Gareth; Hamm, Gregory; Atkinson, James; Jones, Stewart; Bunch, Josephine; Andrén, Per E; Takats, Zoltan; Goodwin, Richard J A; Mastroeni, Pietro.
Afiliación
  • Strittmatter N; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
  • Kanvatirth P; Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, U.K.
  • Inglese P; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, U.K.
  • Race AM; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
  • Nilsson A; Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden.
  • Dannhorn A; Science for Life Laboratory, Spatial Mass Spectrometry, Uppsala University, 751 24 Uppsala, Sweden.
  • Kudo H; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
  • Goldin RD; Division of Digestive Diseases, Section of Pathology, Imperial College London, St. Mary's Hospital, London W2 1NY, U.K.
  • Ling S; Division of Digestive Diseases, Section of Pathology, Imperial College London, St. Mary's Hospital, London W2 1NY, U.K.
  • Wong E; Department of Cellular Pathology, Charing Cross Hospital, London W6 8RF, U.K.
  • Seeliger F; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
  • Serra MP; Biologics Engineering, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
  • Hoffmann S; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
  • Maglennon G; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
  • Hamm G; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
  • Atkinson J; BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, U.K.
  • Jones S; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
  • Bunch J; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
  • Andrén PE; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
  • Takats Z; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
  • Goodwin RJA; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, U.K.
  • Mastroeni P; National Centre of Excellence in Mass Spectrometry Imaging (NiCE-MSI), National Physical Laboratory, Teddington TW11 0LW, U.K.
J Am Soc Mass Spectrom ; 32(12): 2791-2802, 2021 Dec 01.
Article en En | MEDLINE | ID: mdl-34767352
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Salmonella / Salmonella typhimurium / Espectrometría de Masas / Imagen Molecular Límite: Animals Idioma: En Revista: J Am Soc Mass Spectrom Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Salmonella / Salmonella typhimurium / Espectrometría de Masas / Imagen Molecular Límite: Animals Idioma: En Revista: J Am Soc Mass Spectrom Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos